Xellia Pharmaceuticals is investing $25 million to build additional sterile manufacturing capacity at its site in Copenhagen.
Pfizer has sold another Hospira plant, its second in eight weeks, this one a high containment API facility in Boulder, Colorado.
Indian CDMO Piramal Pharma Solutions is beefing up its global API production, including in the U.S., where it has expanded in recent years.
Budding CDMO Avara Pharmaceutical Services has bought a solid dose facility in France from AstraZeneca, its third plant acquisition in three months.
AbbVie began the next phase of its Singapore manufacturing expansion with a new biologics unit that complements the plant's existing API production.
Pharma giant Merck said it will spend $41 million at its Merck Serono facility in Bari, Italy, to build a new injectables production line.
The FDA is concerned that disruption of drug manufacturing in Puerto Rico could lead to critical shortages of some medicines.
AmerisourceBergen has pled guilty and agreed to pay $260 million to settle a federal case over its sales of cancer meds from an unregistered facility.
Generic API maker Cambrex said it will begin a $3.5 million project to improve wastewater processing capabilities at its facility in Sweden.
ADC Biotechnology, a Welsh company specializing in antibody-drug conjugate contract services, said it will invest $11 million to build a new facility in…